Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

218 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Many heart transplant biopsies currently diagnosed as no rejection have mild molecular antibody-mediated rejection-related changes.
Halloran PF, Madill-Thomsen K, Aliabadi-Zuckermann AZ, Cadeiras M, Crespo-Leiro MG, Depasquale EC, Deng M, Gökler J, Kim DH, Kobashigawa J, Macdonald P, Potena L, Shah K, Stehlik J, Zuckermann A. Halloran PF, et al. Among authors: potena l. J Heart Lung Transplant. 2022 Mar;41(3):334-344. doi: 10.1016/j.healun.2021.08.004. Epub 2021 Aug 26. J Heart Lung Transplant. 2022. PMID: 34548198
Cyclosporine lowering with everolimus versus mycophenolate mofetil in heart transplant recipients: long-term follow-up of the SHIRAKISS randomized, prospective study.
Potena L, Prestinenzi P, Bianchi IG, Masetti M, Romani P, Magnani G, Fallani F, Coccolo F, Russo A, Ponticelli C, Rapezzi C, Grigioni F, Branzi A. Potena L, et al. J Heart Lung Transplant. 2012 Jun;31(6):565-70. doi: 10.1016/j.healun.2012.01.002. Epub 2012 Feb 15. J Heart Lung Transplant. 2012. PMID: 22341702 Clinical Trial.
Everolimus versus mycophenolate mofetil in heart transplantation: a randomized, multicenter trial.
Eisen HJ, Kobashigawa J, Starling RC, Pauly DF, Kfoury A, Ross H, Wang SS, Cantin B, Van Bakel A, Ewald G, Hirt S, Lehmkuhl H, Keogh A, Rinaldi M, Potena L, Zuckermann A, Dong G, Cornu-Artis C, Lopez P. Eisen HJ, et al. Among authors: potena l. Am J Transplant. 2013 May;13(5):1203-16. doi: 10.1111/ajt.12181. Epub 2013 Feb 22. Am J Transplant. 2013. PMID: 23433101 Free article. Clinical Trial.
Report from a consensus conference on primary graft dysfunction after cardiac transplantation.
Kobashigawa J, Zuckermann A, Macdonald P, Leprince P, Esmailian F, Luu M, Mancini D, Patel J, Razi R, Reichenspurner H, Russell S, Segovia J, Smedira N, Stehlik J, Wagner F; Consensus Conference participants. Kobashigawa J, et al. J Heart Lung Transplant. 2014 Apr;33(4):327-40. doi: 10.1016/j.healun.2014.02.027. Epub 2014 Mar 5. J Heart Lung Transplant. 2014. PMID: 24661451
Inflammatory cell burden and phenotype in endomyocardial biopsies with antibody-mediated rejection (AMR): a multicenter pilot study from the AECVP.
Fedrigo M, Leone O, Burke MM, Rice A, Toquet C, Vernerey D, Frigo AC, Guillemain R, Pattier S, Smith J, Lota A, Potena L, Bontadini A, Ceccarelli C, Poli F, Feltrin G, Gerosa G, Manzan E, Thiene G, Bruneval P, Angelini A, Duong Van Huyen JP. Fedrigo M, et al. Among authors: potena l. Am J Transplant. 2015 Feb;15(2):526-34. doi: 10.1111/ajt.12976. Am J Transplant. 2015. PMID: 25612500 Free article.
The International Society for Heart and Lung Transplantation Registries in the Era of Big Data With Global Reach.
Stehlik J, Mehra MR, Sweet SC, Kirklin JK, Cypel M, Kirk R, Dipchand AI, Van Raemdonck D, Edwards LB, Mario Bertolotti A, Mejia JC, Torres Navas A, Potena L, Akar R, West LJ, Zuckermann A, Khaliel F, Davis DR, Reichenspurner H. Stehlik J, et al. Among authors: potena l. J Heart Lung Transplant. 2015 Oct;34(10):1225-32. doi: 10.1016/j.healun.2015.08.001. Epub 2015 Aug 28. J Heart Lung Transplant. 2015. PMID: 26454736 No abstract available.
218 results